{"filing":{"accession_number":"0001728117-26-000091","cik":"0001728117","ticker":"GOSS","company_name":"Gossamer Bio, Inc.","form":"8-K","filing_date":"2026-09-09","report_date":"2026-09-09","primary_document":"goss-20260909.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000091/goss-20260909.htm"},"events":[{"id":32254,"run_id":29633,"accession_number":"0001728117-26-000091","anchor_item_number":"8.01","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"summary":"The disclosure announces a 1-for-80 reverse stock split explicitly \"intended to help the Company regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market.\" This is a direct response to delisting risk—the company is taking corrective action to avoid loss of listing. While the reverse split itself is a capital structure event, the material trigger and disclosure focus is the underlying delisting compliance issue, making this a delisting_risk classification.","company_name":"Gossamer Bio, Inc.","ticker":"GOSS","filing_date":"2026-09-09","form":"8-K","submitted_at":null,"items":[{"id":35384,"accession_number":"0001728117-26-000091","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The disclosure announces a 1-for-80 reverse stock split explicitly \"intended to help the Company regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market.\" This is a direct response to delisting risk—the company is taking corrective action to avoid loss of listing. While the reverse split itself is a capital structure event, the material trigger and disclosure focus is the underlying delisting compliance issue, making this a delisting_risk classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T13:02:10.301246+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":35384,"accession_number":"0001728117-26-000091","item_number":"8.01","item_title":"Other Events.","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.92,"reasoning":"The disclosure announces a 1-for-80 reverse stock split explicitly \"intended to help the Company regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Global Select Market.\" This is a direct response to delisting risk—the company is taking corrective action to avoid loss of listing. While the reverse split itself is a capital structure event, the material trigger and disclosure focus is the underlying delisting compliance issue, making this a delisting_risk classification.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-09T13:02:10.301246+00:00","company_name":"Gossamer Bio, Inc.","ticker":"GOSS","filing_date":"2026-09-09"}]}